Publications

Home / Publications

Law No. 9,478, dated June 8, 1997, establishes for the Brazilian Petroleum Agency (ANP) the attribution of stimulating research in the sector.   In view of this, the agreements between the Agency and the Oil Companies for exploration, development and production of oil and natural gas have Research, Development and Innovation clauses that establish the obligation for […]

Leia mais

Numerous social media posts claim that coronavirus is known for years and there are patents covering the virus and possible vaccines. This confusion is due to the lack of information about virus in general. The term “coronavirus” actually refers to a broad family of virus, which includes the SARS-CoV and MERS-CoV. The recent outbreak of […]

Leia mais

The Brazilian PTO published this week new statistics regarding the results of the backlog combat plan, announced and implemented in 2019.   According to official data, the PTO reduced the average prosecution time for patent applications from 10 to 9.3 years. Areas like biotech and polymers, which had an average prosecution time of 11.14 and […]

Leia mais

Our partner, Daniela Fasoli, will speak about new trends in prosecution of pharma patent applications in Brazil.   With a population of more than 200 million people and being the 6th largest pharmaceutical market in the world, Brazil is a top priority for patent investments in the pharma industry. Applicants, however, face several obstacles when prosecuting in […]

Leia mais

Brazil, as many other countries, is currently debating the use of cannabis-derived products. On the Regulatory side, the board of ANVISA (the Brazilian Food and Drug Administration) is analyzing proposals for regulation of medicinal cannabis in Brazil. More especially, two drafts of Resolutions (RDCs) are the focus of discussions: one addresses the technical and administrative […]

Leia mais

  In 2016, the Brazilian Health Regulatory Agency (ANVISA) became a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The ICH brings together regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of drug registration. This measure favors the growth of the national pharmaceutical market and the harmonization of […]

Leia mais

Igor Simões Managing Partner Igor is a Brazilian patent attorney, with a 20-year experience in Intellectual Property prosecution and litigation. He graduated in Chemical Engineering from Federal Fluminense University, in 1999 and Law from Candido Mendes University, in 2009.  Igor qualified as a registered industrial property agent before the Brazilian PTO in 2001. Igor’s experience includes management […]

Leia mais

After more than 17 years of discussions, Brazil finally joined the Madrid Protocol.  President Jair Bolsonaro signed the agreement last week, and it was delivered to WIPO on Wednesday. With this, the PTO formalizes its participation and begins to operate the treaty in October 2019.   One of the main issues for this extremely long […]

Leia mais